310 related articles for article (PubMed ID: 18216017)
1. Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding.
Gelsthorpe ME; Baumann N; Millard E; Gale SE; Langmade SJ; Schaffer JE; Ory DS
J Biol Chem; 2008 Mar; 283(13):8229-36. PubMed ID: 18216017
[TBL] [Abstract][Full Text] [Related]
2. Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERAD.
Schultz ML; Krus KL; Kaushik S; Dang D; Chopra R; Qi L; Shakkottai VG; Cuervo AM; Lieberman AP
Nat Commun; 2018 Sep; 9(1):3671. PubMed ID: 30202070
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.
Pipalia NH; Subramanian K; Mao S; Ralph H; Hutt DM; Scott SM; Balch WE; Maxfield FR
J Lipid Res; 2017 Apr; 58(4):695-708. PubMed ID: 28193631
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.
Rauniyar N; Subramanian K; Lavallée-Adam M; Martínez-Bartolomé S; Balch WE; Yates JR
Mol Cell Proteomics; 2015 Jul; 14(7):1734-49. PubMed ID: 25873482
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts.
Pipalia NH; Cosner CC; Huang A; Chatterjee A; Bourbon P; Farley N; Helquist P; Wiest O; Maxfield FR
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5620-5. PubMed ID: 21436030
[TBL] [Abstract][Full Text] [Related]
6. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele.
Praggastis M; Tortelli B; Zhang J; Fujiwara H; Sidhu R; Chacko A; Chen Z; Chung C; Lieberman AP; Sikora J; Davidson C; Walkley SU; Pipalia NH; Maxfield FR; Schaffer JE; Ory DS
J Neurosci; 2015 May; 35(21):8091-106. PubMed ID: 26019327
[TBL] [Abstract][Full Text] [Related]
7. Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts.
Yu T; Chung C; Shen D; Xu H; Lieberman AP
Hum Mol Genet; 2012 Jul; 21(14):3205-14. PubMed ID: 22505584
[TBL] [Abstract][Full Text] [Related]
8. Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.
Subramanian K; Hutt DM; Scott SM; Gupta V; Mao S; Balch WE
J Biol Chem; 2020 Jun; 295(23):8017-8035. PubMed ID: 32354745
[TBL] [Abstract][Full Text] [Related]
9. Niemann-Pick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterations.
Ribeiro I; Marcão A; Amaral O; Sá Miranda MC; Vanier MT; Millat G
Hum Genet; 2001 Jul; 109(1):24-32. PubMed ID: 11479732
[TBL] [Abstract][Full Text] [Related]
10. High-content screen for modifiers of Niemann-Pick type C disease in patient cells.
Pugach EK; Feltes M; Kaufman RJ; Ory DS; Bang AG
Hum Mol Genet; 2018 Jun; 27(12):2101-2112. PubMed ID: 29659804
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein.
Ohgane K; Karaki F; Noguchi-Yachide T; Dodo K; Hashimoto Y
Bioorg Med Chem Lett; 2014 Aug; 24(15):3480-5. PubMed ID: 24928400
[TBL] [Abstract][Full Text] [Related]
12. The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations.
Macías-Vidal J; Girós M; Guerrero M; Gascón P; Serratosa J; Bachs O; Coll MJ
FEBS J; 2014 Oct; 281(19):4450-66. PubMed ID: 25131710
[TBL] [Abstract][Full Text] [Related]
13. Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.
Sun X; Marks DL; Park WD; Wheatley CL; Puri V; O'Brien JF; Kraft DL; Lundquist PA; Patterson MC; Pagano RE; Snow K
Am J Hum Genet; 2001 Jun; 68(6):1361-72. PubMed ID: 11349231
[TBL] [Abstract][Full Text] [Related]
14. HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts.
Pipalia NH; Saad SZ; Subramanian K; Cross A; Al-Motawa A; Garg K; Blagg BSJ; Neckers L; Helquist P; Wiest O; Ory DS; Maxfield FR
J Lipid Res; 2021; 62():100114. PubMed ID: 34481829
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol overload promotes morphogenesis of a Niemann-Pick C (NPC)-like compartment independent of inhibition of NPC1 or HE1/NPC2 function.
Frolov A; Srivastava K; Daphna-Iken D; Traub LM; Schaffer JE; Ory DS
J Biol Chem; 2001 Dec; 276(49):46414-21. PubMed ID: 11571306
[TBL] [Abstract][Full Text] [Related]
16. Niemann-Pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization.
Watari H; Blanchette-Mackie EJ; Dwyer NK; Glick JM; Patel S; Neufeld EB; Brady RO; Pentchev PG; Strauss JF
Proc Natl Acad Sci U S A; 1999 Feb; 96(3):805-10. PubMed ID: 9927649
[TBL] [Abstract][Full Text] [Related]
17. Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 protein.
Fukuda H; Karaki F; Dodo K; Noguchi-Yachide T; Ishikawa M; Hashimoto Y; Ohgane K
Bioorg Med Chem Lett; 2017 Jun; 27(12):2781-2787. PubMed ID: 28465104
[TBL] [Abstract][Full Text] [Related]
18. A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.
Maue RA; Burgess RW; Wang B; Wooley CM; Seburn KL; Vanier MT; Rogers MA; Chang CC; Chang TY; Harris BT; Graber DJ; Penatti CA; Porter DM; Szwergold BS; Henderson LP; Totenhagen JW; Trouard TP; Borbon IA; Erickson RP
Hum Mol Genet; 2012 Feb; 21(4):730-50. PubMed ID: 22048958
[TBL] [Abstract][Full Text] [Related]
19. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein.
Boadu E; Nelson RC; Francis GA
Biochim Biophys Acta; 2012 Mar; 1821(3):396-404. PubMed ID: 22179027
[TBL] [Abstract][Full Text] [Related]
20. Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.
Millat G; Marçais C; Tomasetto C; Chikh K; Fensom AH; Harzer K; Wenger DA; Ohno K; Vanier MT
Am J Hum Genet; 2001 Jun; 68(6):1373-85. PubMed ID: 11333381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
